世界の心臓バイオマーカー市場2023年-2027年

◆英語タイトル:Global Cardiac Biomarkers Market 2023-2027

Technavioが発行した調査報告書(IRTNTR74940-23)◆商品コード:IRTNTR74940-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年2月2日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テックナビオ社の本調査資料では、世界の心臓バイオマーカー市場規模が2022年から2027年の間に7,880.86百万ドルまで拡大し、予測期間中に年平均12.6%増加すると推測されています。本資料では心臓バイオマーカーの世界市場を多方面に調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、技術別(従来型ラボ検査、POC検査)製品別(トロポニン、BNP・NT-proBNP、CK-MB、ミオグロビン、その他)分析、エンドユーザー別(病院、診療所、診断検査室)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、ドイツ、中国、イギリス、インド)分析、成長要因・課題・動向、企業状況、企業分析などの項目をまとめています。また、本資料で記載されている企業情報には、Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析

・世界の心臓バイオマーカー市場規模:技術別
- 従来型ラボ検査技術の市場規模
- POC検査技術の市場規模

・世界の心臓バイオマーカー市場規模:製品別
- トロポニンの市場規模
- BNP・NT-proBNPの市場規模
- CK-MBの市場規模
- ミオグロビンの市場規模
- その他の市場規模

・世界の心臓バイオマーカー市場規模:エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- 診断検査室における市場規模
- その他エンドユーザーにおける市場規模

・顧客状況
・地域別状況
- 北米の心臓バイオマーカー市場規模
- ヨーロッパの心臓バイオマーカー市場規模
- アジア太平洋の心臓バイオマーカー市場規模
- その他地域の心臓バイオマーカー市場規模
- アメリカの心臓バイオマーカー市場規模
- ドイツの心臓バイオマーカー市場規模
- 中国の心臓バイオマーカー市場規模
- イギリスの心臓バイオマーカー市場規模
- インドの心臓バイオマーカー市場規模

・成長要因・課題・動向
・企業状況
・企業分析

テックナビオ社は、利益・価格・競争・プロモーションなどの重要な変数を解析することで、また、複数の情報源からのデータを調査・統合・統括することにより、心臓バイオマーカー市場の全体像を詳細に提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。これらデータは総合的​で信憑性が高く、一次・二次の広域な調査の結果です。テックナビオ社の市場調査資料は、確かな心臓バイオマーカー市場の成長を予測するために定性的・定量的調査手法を用いた詳細なベンダー選定と分析を提供します。

心臓バイオマーカーの世界市場 2023〜2027年

Technavio社は、心臓バイオマーカー市場をモニターしており、2022年から2027年にかけて7,880.86百万ドルの成長が予測され、予測期間中のCAGRは12.6%で加速すると予測しています。当レポートでは、心臓バイオマーカー市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。CVDの有病率の増加、高齢者人口の増加、M&Aや新製品の上市数の増加が市場を牽引しています。

Technavioの心臓バイオマーカー市場は以下のように区分されます:

・技術別:
– 従来型ラボ検査
– POC検査

・製品別:
– トロポニン
– BNP・NT-proBNP
– CK-MB
– ミオグロビン
– その他

・エンドユーザー別:
– 病院
– 診療所
– 診断研究所

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間における心臓バイオマーカー市場の成長を促進する主な理由の1つとして、個別化医療への注目の高まりを挙げています。また、POCのための迅速診断におけるデジタルヘルスの使用と技術の進歩は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、心臓バイオマーカー市場について以下の分野をカバーしています:
– 心臓バイオマーカー市場のサイジング
– 心臓バイオマーカー市場予測
– 心臓バイオマーカー市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., AgPlus Diagnostics Ltd., and Tosoh Corpなどの企業情報が含まれています。また、心臓バイオマーカー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 08: Executive Summary – Chart on Incremental Growth
o Exhibit 09: Executive Summary – Data Table on Incremental Growth
o Exhibit 10: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 11: Parent market
o Exhibit 12: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 13: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 14: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 15: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cardiac biomarkers market 2017 – 2021
o Exhibit 19: Historic Market Size – Data Table on Global cardiac biomarkers market 2017 – 2021 ($ million)
o 4.2 Technology Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 End-user Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.5 Geography Segment Analysis 2017 – 2021
o Exhibit 23: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.6 Country Segment Analysis 2017 – 2021
o Exhibit 24: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 25: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 31: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Technology
o 6.1 Market segments
o Exhibit 32: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 33: Data Table on Technology – Market share 2022-2027 (%)
o 6.2 Comparison by Technology
o Exhibit 34: Chart on Comparison by Technology
o Exhibit 35: Data Table on Comparison by Technology
o 6.3 Conventional laboratory testing – Market size and forecast 2022-2027
o Exhibit 36: Chart on Conventional laboratory testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 37: Data Table on Conventional laboratory testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Chart on Conventional laboratory testing – Year-over-year growth 2022-2027 (%)
o Exhibit 39: Data Table on Conventional laboratory testing – Year-over-year growth 2022-2027 (%)
o 6.4 POC testing – Market size and forecast 2022-2027
o Exhibit 40: Chart on POC testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 41: Data Table on POC testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 42: Chart on POC testing – Year-over-year growth 2022-2027 (%)
o Exhibit 43: Data Table on POC testing – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Technology
o Exhibit 44: Market opportunity by Technology ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 45: Chart on Product – Market share 2022-2027 (%)
o Exhibit 46: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 47: Chart on Comparison by Product
o Exhibit 48: Data Table on Comparison by Product
o 7.3 Troponin – Market size and forecast 2022-2027
o Exhibit 49: Chart on Troponin – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Data Table on Troponin – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Chart on Troponin – Year-over-year growth 2022-2027 (%)
o Exhibit 52: Data Table on Troponin – Year-over-year growth 2022-2027 (%)
o 7.4 BNP and NT-proBNP – Market size and forecast 2022-2027
o Exhibit 53: Chart on BNP and NT-proBNP – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Data Table on BNP and NT-proBNP – Market size and forecast 2022-2027 ($ million)
o Exhibit 55: Chart on BNP and NT-proBNP – Year-over-year growth 2022-2027 (%)
o Exhibit 56: Data Table on BNP and NT-proBNP – Year-over-year growth 2022-2027 (%)
o 7.5 CK-MB – Market size and forecast 2022-2027
o Exhibit 57: Chart on CK-MB – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Data Table on CK-MB – Market size and forecast 2022-2027 ($ million)
o Exhibit 59: Chart on CK-MB – Year-over-year growth 2022-2027 (%)
o Exhibit 60: Data Table on CK-MB – Year-over-year growth 2022-2027 (%)
o 7.6 Myoglobin – Market size and forecast 2022-2027
o Exhibit 61: Chart on Myoglobin – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on Myoglobin – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on Myoglobin – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on Myoglobin – Year-over-year growth 2022-2027 (%)
o 7.7 Others – Market size and forecast 2022-2027
o Exhibit 65: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Product
o Exhibit 69: Market opportunity by Product ($ million)
• 8 Market Segmentation by End-user
o 8.1 Market segments
o Exhibit 70: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 71: Data Table on End-user – Market share 2022-2027 (%)
o 8.2 Comparison by End-user
o Exhibit 72: Chart on Comparison by End-user
o Exhibit 73: Data Table on Comparison by End-user
o 8.3 Hospitals and clinics – Market size and forecast 2022-2027
o Exhibit 74: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 77: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o 8.4 Diagnostic laboratories – Market size and forecast 2022-2027
o Exhibit 78: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 81: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o 8.5 Market opportunity by End-user
o Exhibit 82: Market opportunity by End-user ($ million)
• 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 10 Geographic Landscape
o 10.1 Geographic segmentation
o Exhibit 84: Chart on Market share by geography 2022-2027 (%)
o Exhibit 85: Data Table on Market share by geography 2022-2027 (%)
o 10.2 Geographic comparison
o Exhibit 86: Chart on Geographic comparison
o Exhibit 87: Data Table on Geographic comparison
o 10.3 North America – Market size and forecast 2022-2027
o Exhibit 88: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 91: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 10.4 Europe – Market size and forecast 2022-2027
o Exhibit 92: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 95: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 10.5 Asia – Market size and forecast 2022-2027
o Exhibit 96: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 99: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 10.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 100: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 103: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 10.7 US – Market size and forecast 2022-2027
o Exhibit 104: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 107: Data Table on US – Year-over-year growth 2022-2027 (%)
o 10.8 Germany – Market size and forecast 2022-2027
o Exhibit 108: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 111: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 10.9 China – Market size and forecast 2022-2027
o Exhibit 112: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 114: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 115: Data Table on China – Year-over-year growth 2022-2027 (%)
o 10.10 UK – Market size and forecast 2022-2027
o Exhibit 116: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 117: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 118: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 119: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 10.11 India – Market size and forecast 2022-2027
o Exhibit 120: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 121: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 122: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 123: Data Table on India – Year-over-year growth 2022-2027 (%)
o 10.12 Market opportunity by geography
o Exhibit 124: Market opportunity by geography ($ million)
• 11 Drivers, Challenges, and Trends
o 11.1 Market drivers
o 11.2 Market challenges
o 11.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2022 and 2027
o 11.4 Market trends
• 12 Vendor Landscape
o 12.1 Overview
o 12.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 12.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 12.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 13 Vendor Analysis
o 13.1 Vendors covered
o Exhibit 129: Vendors covered
o 13.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 13.3 Abbott Laboratories
o Exhibit 131: Abbott Laboratories – Overview
o Exhibit 132: Abbott Laboratories – Business segments
o Exhibit 133: Abbott Laboratories – Key news
o Exhibit 134: Abbott Laboratories – Key offerings
o Exhibit 135: Abbott Laboratories – Segment focus
o 13.4 BG Medicine Inc.
o Exhibit 136: BG Medicine Inc. – Overview
o Exhibit 137: BG Medicine Inc. – Product / Service
o Exhibit 138: BG Medicine Inc. – Key offerings
o 13.5 Bio Rad Laboratories Inc.
o Exhibit 139: Bio Rad Laboratories Inc. – Overview
o Exhibit 140: Bio Rad Laboratories Inc. – Business segments
o Exhibit 141: Bio Rad Laboratories Inc. – Key news
o Exhibit 142: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 143: Bio Rad Laboratories Inc. – Segment focus
o 13.6 bioMerieux SA
o Exhibit 144: bioMerieux SA – Overview
o Exhibit 145: bioMerieux SA – Product / Service
o Exhibit 146: bioMerieux SA – Key news
o Exhibit 147: bioMerieux SA – Key offerings
o 13.7 Boditech Med Inc.
o Exhibit 148: Boditech Med Inc. – Overview
o Exhibit 149: Boditech Med Inc. – Key offerings
o 13.8 Creative Diagnostics
o Exhibit 150: Creative Diagnostics – Overview
o Exhibit 151: Creative Diagnostics – Product / Service
o Exhibit 152: Creative Diagnostics – Key offerings
o 13.9 Diazyme Laboratories Inc.
o Exhibit 153: Diazyme Laboratories Inc. – Overview
o Exhibit 154: Diazyme Laboratories Inc. – Product / Service
o Exhibit 155: Diazyme Laboratories Inc. – Key offerings
o 13.10 F. Hoffmann La Roche Ltd.
o Exhibit 156: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 157: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 158: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 159: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 160: F. Hoffmann La Roche Ltd. – Segment focus
o 13.11 Lepu Medical Technology Beijing Co. Ltd.
o Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. – Overview
o Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. – Product / Service
o Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. – Key offerings
o 13.12 LifeSign LLC
o Exhibit 164: LifeSign LLC – Overview
o Exhibit 165: LifeSign LLC – Product / Service
o Exhibit 166: LifeSign LLC – Key offerings
o 13.13 LSI Medience Corp.
o Exhibit 167: LSI Medience Corp. – Overview
o Exhibit 168: LSI Medience Corp. – Product / Service
o Exhibit 169: LSI Medience Corp. – Key offerings
o 13.14 Randox Laboratories Ltd.
o Exhibit 170: Randox Laboratories Ltd. – Overview
o Exhibit 171: Randox Laboratories Ltd. – Product / Service
o Exhibit 172: Randox Laboratories Ltd. – Key offerings
o 13.15 Response Biomedical Corp.
o Exhibit 173: Response Biomedical Corp. – Overview
o Exhibit 174: Response Biomedical Corp. – Product / Service
o Exhibit 175: Response Biomedical Corp. – Key offerings
o 13.16 Siemens Healthineers AG
o Exhibit 176: Siemens Healthineers AG – Overview
o Exhibit 177: Siemens Healthineers AG – Business segments
o Exhibit 178: Siemens Healthineers AG – Key news
o Exhibit 179: Siemens Healthineers AG – Key offerings
o Exhibit 180: Siemens Healthineers AG – Segment focus
o 13.17 Signosis Inc.
o Exhibit 181: Signosis Inc. – Overview
o Exhibit 182: Signosis Inc. – Product / Service
o Exhibit 183: Signosis Inc. – Key offerings
• 14 Appendix
o 14.1 Scope of the report
o 14.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 14.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 14.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 14.5 List of abbreviations
o Exhibit 190: List of abbreviations
o investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Market Segmentation by End-user
Exhibits8: Executive Summary – Chart on Incremental Growth
Exhibits9: Executive Summary – Data Table on Incremental Growth
Exhibits10: Executive Summary – Chart on Vendor Market Positioning
Exhibits11: Parent market
Exhibits12: Market Characteristics
Exhibits13: Offerings of vendors included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits19: Historic Market Size – Data Table on Global cardiac biomarkers market 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits23: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits24: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits25: Five forces analysis – Comparison between 2022 and 2027
Exhibits26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits28: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits29: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits30: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits31: Chart on Market condition – Five forces 2022 and 2027
Exhibits32: Chart on Technology – Market share 2022-2027 (%)
Exhibits33: Data Table on Technology – Market share 2022-2027 (%)
Exhibits34: Chart on Comparison by Technology
Exhibits35: Data Table on Comparison by Technology
Exhibits36: Chart on Conventional laboratory testing – Market size and forecast 2022-2027 ($ million)
Exhibits37: Data Table on Conventional laboratory testing – Market size and forecast 2022-2027 ($ million)
Exhibits38: Chart on Conventional laboratory testing – Year-over-year growth 2022-2027 (%)
Exhibits39: Data Table on Conventional laboratory testing – Year-over-year growth 2022-2027 (%)
Exhibits40: Chart on POC testing – Market size and forecast 2022-2027 ($ million)
Exhibits41: Data Table on POC testing – Market size and forecast 2022-2027 ($ million)
Exhibits42: Chart on POC testing – Year-over-year growth 2022-2027 (%)
Exhibits43: Data Table on POC testing – Year-over-year growth 2022-2027 (%)
Exhibits44: Market opportunity by Technology ($ million)
Exhibits45: Chart on Product – Market share 2022-2027 (%)
Exhibits46: Data Table on Product – Market share 2022-2027 (%)
Exhibits47: Chart on Comparison by Product
Exhibits48: Data Table on Comparison by Product
Exhibits49: Chart on Troponin – Market size and forecast 2022-2027 ($ million)
Exhibits50: Data Table on Troponin – Market size and forecast 2022-2027 ($ million)
Exhibits51: Chart on Troponin – Year-over-year growth 2022-2027 (%)
Exhibits52: Data Table on Troponin – Year-over-year growth 2022-2027 (%)
Exhibits53: Chart on BNP and NT-proBNP – Market size and forecast 2022-2027 ($ million)
Exhibits54: Data Table on BNP and NT-proBNP – Market size and forecast 2022-2027 ($ million)
Exhibits55: Chart on BNP and NT-proBNP – Year-over-year growth 2022-2027 (%)
Exhibits56: Data Table on BNP and NT-proBNP – Year-over-year growth 2022-2027 (%)
Exhibits57: Chart on CK-MB – Market size and forecast 2022-2027 ($ million)
Exhibits58: Data Table on CK-MB – Market size and forecast 2022-2027 ($ million)
Exhibits59: Chart on CK-MB – Year-over-year growth 2022-2027 (%)
Exhibits60: Data Table on CK-MB – Year-over-year growth 2022-2027 (%)
Exhibits61: Chart on Myoglobin – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Myoglobin – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Myoglobin – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Myoglobin – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits69: Market opportunity by Product ($ million)
Exhibits70: Chart on End-user – Market share 2022-2027 (%)
Exhibits71: Data Table on End-user – Market share 2022-2027 (%)
Exhibits72: Chart on Comparison by End-user
Exhibits73: Data Table on Comparison by End-user
Exhibits74: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits75: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits76: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits77: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits78: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits79: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits80: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits81: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits82: Market opportunity by End-user ($ million)
Exhibits83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits84: Chart on Market share by geography 2022-2027 (%)
Exhibits85: Data Table on Market share by geography 2022-2027 (%)
Exhibits86: Chart on Geographic comparison
Exhibits87: Data Table on Geographic comparison
Exhibits88: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits89: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits90: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits91: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits92: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits93: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits94: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits95: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits96: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits97: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits98: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits99: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits100: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits101: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits102: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits103: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits104: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits105: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits106: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits107: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits108: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits109: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits110: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits112: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits113: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits114: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits115: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits116: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits117: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits118: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits119: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits120: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits121: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits122: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits123: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits124: Market opportunity by geography ($ million)
Exhibits125: Impact of drivers and challenges in 2022 and 2027
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: Abbott Laboratories – Overview
Exhibits132: Abbott Laboratories – Business segments
Exhibits133: Abbott Laboratories – Key news
Exhibits134: Abbott Laboratories – Key offerings
Exhibits135: Abbott Laboratories – Segment focus
Exhibits136: BG Medicine Inc. – Overview
Exhibits137: BG Medicine Inc. – Product / Service
Exhibits138: BG Medicine Inc. – Key offerings
Exhibits139: Bio Rad Laboratories Inc. – Overview
Exhibits140: Bio Rad Laboratories Inc. – Business segments
Exhibits141: Bio Rad Laboratories Inc. – Key news
Exhibits142: Bio Rad Laboratories Inc. – Key offerings
Exhibits143: Bio Rad Laboratories Inc. – Segment focus
Exhibits144: bioMerieux SA – Overview
Exhibits145: bioMerieux SA – Product / Service
Exhibits146: bioMerieux SA – Key news
Exhibits147: bioMerieux SA – Key offerings
Exhibits148: Boditech Med Inc. – Overview
Exhibits149: Boditech Med Inc. – Key offerings
Exhibits150: Creative Diagnostics – Overview
Exhibits151: Creative Diagnostics – Product / Service
Exhibits152: Creative Diagnostics – Key offerings
Exhibits153: Diazyme Laboratories Inc. – Overview
Exhibits154: Diazyme Laboratories Inc. – Product / Service
Exhibits155: Diazyme Laboratories Inc. – Key offerings
Exhibits156: F. Hoffmann La Roche Ltd. – Overview
Exhibits157: F. Hoffmann La Roche Ltd. – Business segments
Exhibits158: F. Hoffmann La Roche Ltd. – Key news
Exhibits159: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits161: Lepu Medical Technology Beijing Co. Ltd. – Overview
Exhibits162: Lepu Medical Technology Beijing Co. Ltd. – Product / Service
Exhibits163: Lepu Medical Technology Beijing Co. Ltd. – Key offerings
Exhibits164: LifeSign LLC – Overview
Exhibits165: LifeSign LLC – Product / Service
Exhibits166: LifeSign LLC – Key offerings
Exhibits167: LSI Medience Corp. – Overview
Exhibits168: LSI Medience Corp. – Product / Service
Exhibits169: LSI Medience Corp. – Key offerings
Exhibits170: Randox Laboratories Ltd. – Overview
Exhibits171: Randox Laboratories Ltd. – Product / Service
Exhibits172: Randox Laboratories Ltd. – Key offerings
Exhibits173: Response Biomedical Corp. – Overview
Exhibits174: Response Biomedical Corp. – Product / Service
Exhibits175: Response Biomedical Corp. – Key offerings
Exhibits176: Siemens Healthineers AG – Overview
Exhibits177: Siemens Healthineers AG – Business segments
Exhibits178: Siemens Healthineers AG – Key news
Exhibits179: Siemens Healthineers AG – Key offerings
Exhibits180: Siemens Healthineers AG – Segment focus
Exhibits181: Signosis Inc. – Overview
Exhibits182: Signosis Inc. – Product / Service
Exhibits183: Signosis Inc. – Key offerings
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の心臓バイオマーカー市場2023年-2027年(Global Cardiac Biomarkers Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆